Archive - October 2024
Clinical Practice Guideline Updated for Migraine, Tension-Type Headache
ACAAI: ICS + Formoterol and ICS + SABA Better Than SABA Alone for Asthma
Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries
UroGen Submits Completed UGN-102 NDA Seeking Approval as the First FDA-Approved Treatment for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
USPSTF Recommends Screening for Domestic Violence in Pregnant, Postpartum Women
Clinicians Often Fail to Rescue Women With Complications After High-Risk Surgery
Iterum Therapeutics Provides Update on FDA Advisory Committee Discussion of Oral Sulopenem for the Treatment of uUTI in Adult Women
Many Seniors at Risk for Financial Precarity From Cost of Hospital Stay